Kenvue Inc. Common Stock vs Invesco NASDAQ 100 ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B), while Invesco NASDAQ 100 ETF trades at $309.39 (market cap $113.40B). The key difference: Invesco NASDAQ 100 ETF is far larger — about 3.3× Kenvue Inc. Common Stock's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Invesco NASDAQ 100 ETF pays none. Which is the better fit depends on your goals.
| KVUE | QQQM | |
|---|---|---|
Market Cap | $34.06B | $113.40B |
Volume | 23,267,228 | 2,866,236 |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $19.83 | $312.76 |
52-Week Low | $14.11 | $229.87 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 54 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QQQM trades at $307.85, down 1.33% on the day, with a bullish technical outlook supported by moving averages. The ETF benefits from Nasdaq-100 exposure and a competitive 0.15% expense ratio. Recent institutional buying includes QRG Capital Management increasing its position by 207.5% in Q2 2026. Technical indicators show support at $305 and resistance at $311.
The outlook remains positive given Nasdaq-100 strength and lower fees than QQQ. Risks include market concentration in technology stocks and potential tax implications of distributions. Analyst sentiment favors QQQM for core growth allocations, though some prefer equal-weight alternatives for diversification.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.
Read more on QQQM →